Ending Temporary Part D Subsidies Makes Sense

The Trump Administration announced yesterday that it would finish phasing out a temporary subsidy program for Medicare prescription drug plans—a sensible decision given the program’s increased generosity and low premiums. Future changes should balance cost containment against any additional federal support.